Iran, Islamic Republic of vs Timor-Leste: Average cost of multi drug-resistant tuberculosis treatment
Iran, Islamic Republic of
28,730 constant 2022 US$
in 2022
Timor-Leste
50,471 constant 2022 US$
in 2024
Iran, Islamic Republic of rank
3rd
Timor-Leste rank
2nd
Average cost of multi drug-resistant tuberculosis treatment over time
- Iran, Islamic Republic of
- Timor-Leste
How they compare
Timor-Leste currently reports 50,471 constant 2022 US$ against 28,730 constant 2022 US$ in Iran, Islamic Republic of, a difference of 21,741 constant 2022 US$.
That makes Timor-Leste's figure about 1.8 times Iran, Islamic Republic of's.
Across all 6 years both countries report, Iran, Islamic Republic of has been ahead every year.
Iran, Islamic Republic of ranks 3rd and Timor-Leste ranks 2nd of 92 countries.
Iran, Islamic Republic of has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Iran, Islamic Republic of | Timor-Leste | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 8,842 constant 2022 US$ | 1,816 constant 2022 US$ | 7,026 constant 2022 US$ | Iran, Islamic Republic of |
| 2020s | 20,687 constant 2022 US$ | 357.33 constant 2022 US$ | 20,329 constant 2022 US$ | Iran, Islamic Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Iran, Islamic Republic of or Timor-Leste?
- Timor-Leste, at 50,471 constant 2022 US$ against 28,730 constant 2022 US$ in Iran, Islamic Republic of as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Iran, Islamic Republic of and Timor-Leste?
- 21,741 constant 2022 US$, with Timor-Leste ahead.
- How many years of comparable data are there for Iran, Islamic Republic of and Timor-Leste?
- 6 years are reported by both, from 2017 to 2022.
- How do Iran, Islamic Republic of and Timor-Leste rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Iran, Islamic Republic of ranks 3rd and Timor-Leste ranks 2nd of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.